Background α-fetoprotein (AFP) response has been demonstrated as a biomarker for unresectable
hepatocellular carcinoma (uHCC) patients receiving immunotherapy, but its definition …

Purpose The present study aimed to identify independent clinicopathological and socio-economic
prognostic factors associated with overall survival of early-onset colorectal cancer (EO-…

Background: The selection criterion for hepatic resection(HR) in intermediate-stage(IM)
hepatocellular carcinoma(HCC) is still controversial. We used real-world data to evaluate the …

Background α-fetoprotein (AFP) response has been proven a key tumor marker for
hepatocellular carcinoma (HCC), but its definition remains controversial. This study aims to …

Background: A less effective nomogram for patients with intermediate-stage hepatocellular
carcinoma (HCC) to predict overall survival (OS) is available. This study aimed to investigate …

Introduction Sunitinib-induced diarrhea seriously affects the prognosis of patients with
metastatic renal cell carcinoma (mRCC) and reduces their quality of life. We aim to explore and …

Background Preclinical studies showed that antibiotic exposure played a role in clinical
outcomes in patients with chemotherapy via modulation of microbiota. However, it remains …

Background Trastuzumab-containing chemotherapy is the first-line treatment for advanced
gastric cancer (GC) with HER2 positive. Although PD-1 inhibitors significantly improved the …

Objectives To explore the non-linear relationship between platelet count (PLT) and hepatocellular
carcinoma (HCC) overall survival (OS). Setting The study was done in Sun Yat-sen …

Background Transarterial chemoembolization (TACE) is the recommended first-line treatment
for intermediate-stage Hepatocellular carcinoma (HCC) patients. However, predicting the …